Global Jieyu Anshen Granules Market Growth 2025-2031

The global Jieyu Anshen Granules market size is predicted to grow from US$ 48 million in 2025 to US$ 60.6 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031.

Jieyu Anshen Granule is a Chinese patent medicine, mainly used to treat various symptoms caused by emotional distress and liver qi stagnation, such as anxiety, depression, insomnia, irritability, etc. It is based on the theory of traditional Chinese medicine and is combined with a variety of Chinese medicinal materials that have the effects of soothing the liver and relieving depression, nourishing the heart and calming the mind. It regulates the circulation of qi and blood and the functions of the internal organs in the human body to relieve mental stress and improve emotional state.

United States market for Jieyu Anshen Granules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Jieyu Anshen Granules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Jieyu Anshen Granules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Jieyu Anshen Granules players cover Sichuan Senke Pharmaceutical Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Jilin Kangfu Pharmaceutical Co., Ltd., Jilin Jierji Pharmaceutical Co., Ltd., Dalian Aotai Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Jieyu Anshen Granules Industry Forecast” looks at past sales and reviews total world Jieyu Anshen Granules sales in 2024, providing a comprehensive analysis by region and market sector of projected Jieyu Anshen Granules sales for 2025 through 2031. With Jieyu Anshen Granules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Jieyu Anshen Granules industry.

This Insight Report provides a comprehensive analysis of the global Jieyu Anshen Granules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Jieyu Anshen Granules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Jieyu Anshen Granules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Jieyu Anshen Granules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Jieyu Anshen Granules.

This report presents a comprehensive overview, market shares, and growth opportunities of Jieyu Anshen Granules market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Sucrose-free Type
Sucrose-containing Type

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sichuan Senke Pharmaceutical Co., Ltd.
Henan Furentang Pharmaceutical Co., Ltd.
Jilin Kangfu Pharmaceutical Co., Ltd.
Jilin Jierji Pharmaceutical Co., Ltd.
Dalian Aotai Pharmaceutical Co., Ltd.
Beijing Yadong Biopharmaceutical Co., Ltd.
Siping Zhenghe Pharmaceutical Co., Ltd.
Jilin Zixin Pharmaceutical Co., Ltd.
Jilin Hengjin Pharmaceutical Co., Ltd.
Shenwei Pharmaceutical Group Co., Ltd.
Liaoning Xingao Pharmaceutical Co., Ltd.
Tonghua Limin Pharmaceutical Co., Ltd.
Jilin Songliao Pharmaceutical Co., Ltd.
Qinhuangdao Runqing Pharmaceutical Co., Ltd.
Bizhigao Pharmaceutical Co., Ltd.
Jilin Changyuan Pharmaceutical Co., Ltd.
Jilin Jinghui Pharmaceutical Co., Ltd.
Huaihua Zhenghao Pharmaceutical Co., Ltd.
Harbin Yizhou Pharmaceutical Co., Ltd.
Liaoning Haizhou Pharmaceutical Co., Ltd.
Jilin Jichun Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Jieyu Anshen Granules market?

What factors are driving Jieyu Anshen Granules market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Jieyu Anshen Granules market opportunities vary by end market size?

How does Jieyu Anshen Granules break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.